tiprankstipranks
Trending News
More News >
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Income Statement

Compare
3 Followers

VitaSpring Biomedical Income Statement

Last quarter (Q3 2024), VitaSpring Biomedical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, VitaSpring Biomedical's net income was $0.00. See VitaSpring Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 0.00$ 5.61M$ 248.20K$ 15.14K$ 17.18K
Gross Profit
$ 0.00$ 2.07M$ 112.20K$ 1.70K$ 13.27K
Operating Expenses
$ 0.00$ 584.53K$ 536.91K$ 21.18K$ 34.60K
Depreciation and Amortization
$ 167.90K-$ 450.00$ 450.00-
EBITDA
$ 0.00$ 1.49M$ -424.71K$ -19.04K$ -21.95K
Operating Income
$ 0.00$ 1.48M$ -425.38K$ -19.49K$ -21.33K
Other Income/Expenses
$ 0.00$ -2.36K$ -670.00$ 26.41K$ 0.00
Pretax Income
$ 0.00$ 1.48M$ -425.38K$ 6.92K$ -22.40K
Net Income
$ 0.00$ 1.26M$ -425.38K$ 24.29K$ -22.40K
Per Share Metrics
Basic EPS
$ 0.00$ 0.01$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.01$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 205.98M 91.09M 54.51M 25.15M
Weighted Average Shares Outstanding (Diluted)
0.00 205.98M 91.09M 54.51M 25.15M
Currency in USD

VitaSpring Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis